ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Metabolic Syndrome in Atahualpa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01770054
Recruitment Status : Completed
First Posted : January 17, 2013
Last Update Posted : March 8, 2013
Sponsor:
Information provided by (Responsible Party):
Oscar H. Del Brutto, MD, Hospital Clínica Kennedy

January 15, 2013
January 17, 2013
March 8, 2013
January 2013
March 2013   (Final data collection date for primary outcome measure)
Prevalence of metabolic syndrome [ Time Frame: 5 months ]
determination of the metabolic syndrome in subjects aged 40 years or more
Same as current
Complete list of historical versions of study NCT01770054 on ClinicalTrials.gov Archive Site
Genetic testing [ Time Frame: 5 months ]
Blood will be taken to evaluate the ADN pattern of this population, to compare with other Amerindian populations with a proven high prevalence of diabetes mellitus and metabolic syndrome
Same as current
determination of the prevalence of hyperinsulinemia [ Time Frame: 5 months ]
plasma insulin levels will be determined
Same as current
 
Prevalence of Metabolic Syndrome in Atahualpa
Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.
A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.
Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.
Observational [Patient Registry]
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
2 Months
Retention:   Samples With DNA
Description:
Blood
Non-Probability Sample
all Atahualpa residents aged 40 years or more
Metabolic Syndrome
Other: obtention of a blood sample
a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing
obtention of a blood sample
all Atahualpa residents aged 40 years or more
Intervention: Other: obtention of a blood sample
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
517
600
March 2013
March 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Atahualpa resident aged 40 years or more

Exclusion Criteria:

  • non-consenting persons
Sexes Eligible for Study: All
40 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Ecuador
 
 
NCT01770054
TAP 001-2013
001-2013-01 ( Other Grant/Funding Number: Universidad de Especialidades Espiritu Santo )
No
Not Provided
Not Provided
Oscar H. Del Brutto, MD, Hospital Clínica Kennedy
Hospital Clínica Kennedy
Not Provided
Principal Investigator: Oscar H Del Brutto, MD Universidad de Especialidades del Espíritu Santo
Hospital Clínica Kennedy
March 2013